Josep Maria Cornet Masana
Scientist at Nuage Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Catalan Native or bilingual proficiency
-
Spanish Native or bilingual proficiency
-
English Professional working proficiency
-
German Limited working proficiency
-
French Elementary proficiency
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Credentials
-
Advanced Enterpreneurship Programme (adapted to tech transfer)
La Salle Corporate TrainingSep, 2021- Sep, 2024 -
Medicinal Chemistry: The Molecular Basis of Drug Discovery
edXFeb, 2018- Sep, 2024 -
FELASA B-level certification for Animal Experimentation (rodents and fish)
Generalitat de CatalunyaOct, 2016- Sep, 2024 -
Philosophy and the Sciences (with distinction)
CourseraJan, 2015- Sep, 2024 -
Ethical and Social Challenges of Genomic and Precision Medicine
CourseraNov, 2014- Sep, 2024 -
Global Health: An Interdisciplinary Overview
CourseraDec, 2013- Sep, 2024 -
Writing in the Sciences (online)
Stanford University School of MedicineSep, 2013- Sep, 2024 -
Zertifikat B2 - Certificate of advanced level in German (B2)
Official Language School Certification, Government of CataloniaJun, 2013- Sep, 2024 -
Certificat de Nivell Superior de Català (D)
-Jul, 2009- Sep, 2024
Experience
-
Nuage Therapeutics
-
Spain
-
Biotechnology Research
-
1 - 100 Employee
-
Scientist
-
Apr 2022 - Present
-
-
-
BioExpert Network
-
Spain
-
Biotechnology Research
-
1 - 100 Employee
-
Consultant
-
Jan 2019 - Apr 2022
-
-
-
Josep Carreras Leukaemia Research Institute
-
Spain
-
Research Services
-
100 - 200 Employee
-
Postdoctoral Researcher
-
Sep 2018 - Apr 2022
Basic & applied hematology, leading of a drug discovery project
-
-
Predoctoral Researcher
-
Sep 2015 - Sep 2018
"Repositioning of lysosomotropic antihistamines for hematological neoplasias"
-
-
Research assistant
-
Apr 2015 - Aug 2015
Study on immunological factors related to myelodysplasia progression to acute myeloid leukemia, new insights into leukemogenesis.
-
-
-
Leukos Biotech
-
Spain
-
Pharmaceutical Manufacturing
-
Lab Manager
-
Jan 2020 - Jun 2020
Managing preclinical testing of a newly developed family of antileukemic compounds Managing preclinical testing of a newly developed family of antileukemic compounds
-
-
-
-
MSc Thesis
-
Nov 2013 - Jul 2014
Research in the Leukemia Stem Cells group led by Dr. Ruth M. Risueño. The research was focused on the study of a drug with preliminary activity against acute myeloid leukemia, particularly the study of its effects and mechanisms in vitro. Research in the Leukemia Stem Cells group led by Dr. Ruth M. Risueño. The research was focused on the study of a drug with preliminary activity against acute myeloid leukemia, particularly the study of its effects and mechanisms in vitro.
-
-
-
University of Barcelona
-
Spain
-
Higher Education
-
1 - 100 Employee
-
BSc Thesis
-
Oct 2012 - Jul 2013
Research in the Group of Biotechnology and Molecular Biology of Isoprenoids (Biochemistry and Molecular Biology Department, Biology School, Universitat de Barcelona). My tasks were focused on the research of specific aptamers against bacterial enzymes by means of Flumag-SELEX procedures, as a first step to develop alternative antibacterials and antimalarials. Research in the Group of Biotechnology and Molecular Biology of Isoprenoids (Biochemistry and Molecular Biology Department, Biology School, Universitat de Barcelona). My tasks were focused on the research of specific aptamers against bacterial enzymes by means of Flumag-SELEX procedures, as a first step to develop alternative antibacterials and antimalarials.
-
-
Education
-
Universitat de Barcelona
PhD, Biomedicine -
Universitat de Barcelona
MSc Molecular Biotechnology -
Universitat de Barcelona
BSc Biochemistry -
Escola Costa i Llobera, Barcelona